आईएसएसएन: 1165-158X

सेलुलर और आणविक जीव विज्ञान

खुला एक्सेस

हमारा समूह 1000 से अधिक वैज्ञानिक सोसायटी के सहयोग से हर साल संयुक्त राज्य अमेरिका, यूरोप और एशिया में 3000+ वैश्विक सम्मेलन श्रृंखला कार्यक्रम आयोजित करता है और 700+ ओपन एक्सेस जर्नल प्रकाशित करता है जिसमें 50000 से अधिक प्रतिष्ठित व्यक्तित्व, प्रतिष्ठित वैज्ञानिक संपादकीय बोर्ड के सदस्यों के रूप में शामिल होते हैं।

ओपन एक्सेस जर्नल्स को अधिक पाठक और उद्धरण मिल रहे हैं
700 जर्नल और 15,000,000 पाठक प्रत्येक जर्नल को 25,000+ पाठक मिल रहे हैं

में अनुक्रमित
  • गूगल ज्ञानी
  • शेरपा रोमियो
  • जेनेमिक्स जर्नलसीक
  • RefSeek
  • हमदर्द विश्वविद्यालय
  • ईबीएससीओ एज़
  • प्रोक्वेस्ट सम्मन
  • पबलोन्स
  • आईसीएमजेई
इस पृष्ठ को साझा करें

अमूर्त

Mycobacterium tuberculosis HtdY, a Novel Immunostimulatory Antigen, Drives Th1-type T Cell Immunity via TLR4-mediated Activation of Dendritic Cells.

Xiaoli Yu, Xuefang Li, Peng Hu, Yang Li, Fang Zhou, Ke Zhang, Xinqian Wang, Danni Wang, Shulin Zhang

Mycobacterium tuberculosis (MTB), the etiological factor of tuberculosis (TB), is among the most successful of intracellular pathogen that regulates the host immune response. Cellular immune responses perform a pivotal function in host defence against MTB. Thus, it is vital to understand the antigens which drive immune protection, especially Th1-type cellular immunity. The role of 3-hydroxyacyl-l-thioester dehydratase (HtdY, Rv3389c) of MTB in immunological protection was observed in dendritic cell (DC) activation and T cell immunity herein. Recombinant HtdY was applied for inducing maturation and activation of DCs obtained from murine bone marrow. TLR4 and TLR2 knockout mice and pharmacological inhibitors were used to investigate the mechanism by which HtdY activates DCs. MLR assay was performed to characterize HtdY activity with respect to DC activation and T cell polarization. The alteration of cytokines secretion by human PBMCs elicited by HtdY was observed. We found that HtdY prompted DC maturation and activation through augmenting the expression of surface molecule CD80, CD86 and MHC II, and the release of pro-inflammatory cytokines including IL-1β, IL-6, IL-12 and TNF-α from DCs. HtdY-drived DC activation involved TLR4 activation and mitogen-activated protein kinases (MAPKs) signaling pathway. DCs treated with HtdY induced naïve CD4+ T cells to produce IFN-γ. Human PBMCs had higher TNF-α and lower IL-10 response to HtdY in active TB group than that in control group (p<0.01). Our results indicated that HtdY possesses potential to drive Th1-type cellular immunity by TLR4- mediated activation of DCs.